ARVINAS, INC. (ARVN) Debt / Equity
- 2026-06-30: Debt/Equity Ratio 0.
- 2026-03-31: Debt/Equity Ratio 0.
- 2025-12-31: Debt/Equity Ratio 0.
- 2025-09-30: Debt/Equity Ratio 0.
Complete source-backed debt/equity ratio history.
- Available history
- 2017-12-31 to 2026-06-30
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2026-06-30 | 0 |
| 2026-03-31 | 0 |
| 2025-12-31 | 0 |
| 2025-09-30 | 0 |
| 2025-06-30 | 0 |
| 2025-03-31 | 0 |
| 2024-12-31 | 0 |
| 2024-09-30 | 0 |
| 2024-06-30 | 0 |
| 2024-03-31 | 0 |
| 2023-12-31 | 0 |
| 2023-09-30 | 0 |
| 2023-06-30 | 0 |
| 2023-03-31 | 0 |
| 2022-12-31 | 0 |
| 2019-06-30 | 0.02 |
| 2019-03-31 | 0.02 |
| 2018-12-31 | 0.02 |
| 2018-09-30 | -0.01 |
| 2017-12-31 | -0.01 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-31 | 0 |
| 2024-12-31 | 0 |
| 2023-12-31 | 0 |
| 2022-12-31 | 0 |
| 2018-12-31 | 0.02 |
| 2017-12-31 | -0.01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |